Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats
Mirodenafil is a phosphodiesterase 5 (PDE5) inhibitor with high specificity for its target and good blood-brain barrier permeability. The drug, which is currently used for treatment of erectile dysfunction, reduces Aβ and pTau levels and improves cognitive function in mouse models of Alzheimer'...
Saved in:
Main Authors: | Fred Kim, Padmanabh Singh, Hyunji Jo, Tianyang Xi, Dong-Keun Song, Sae Kwang Ku, Jai Jun Choung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Neurotherapeutics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924001508 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01) -
Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis
by: YAO Xinyi, et al.
Published: (2024-11-01) -
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01) -
Neuroprotective effects of quercetin on hippocampal CA1 neurons following middle cerebral artery ischemia‒reperfusion in male rats: a behavioral, biochemical, and histological study
by: Mehran Mahyar, et al.
Published: (2025-01-01) -
Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
by: Julien Clain, et al.
Published: (2025-06-01)